1. Home
  2. BLZE vs MDWD Comparison

BLZE vs MDWD Comparison

Compare BLZE & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$15.66

Market Cap

218.8M

Sector

Technology

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$14.94

Market Cap

181.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
MDWD
Founded
2007
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
181.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
BLZE
MDWD
Price
$15.66
$14.94
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$7.60
$36.00
AVG Volume (30 Days)
4.5M
84.7K
Earning Date
05-04-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
58.56
N/A
EPS
N/A
N/A
Revenue
$145,835,000.00
N/A
Revenue This Year
$10.16
$48.92
Revenue Next Year
$10.91
$35.04
P/E Ratio
N/A
N/A
Revenue Growth
14.27
N/A
52 Week Low
$3.26
$13.54
52 Week High
$16.59
$21.26

Technical Indicators

Market Signals
Indicator
BLZE
MDWD
Relative Strength Index (RSI) 82.62 51.16
Support Level $3.93 $13.65
Resistance Level N/A $14.99
Average True Range (ATR) 1.21 0.53
MACD 0.68 0.17
Stochastic Oscillator 90.08 69.33

Price Performance

Historical Comparison
BLZE
MDWD

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: